Is $5-$7 pps after a +++ human clinical trial result a "low" estimate. There are several other milestones that could drive the stock to this level first--NASDAQ listing/announcement of approval of the clinical trials/opening of the manufacturing facility/possible take over bid by large pharmaceutical--can't believe that +++ human trial would only raise pps to this level
Depends on the order of things. FDA nod and another lesser event could bring $4.50. Successful results would deserve more than the $5 - $7, but would it go to $10? Up-listing will help as would progress with the other lines. Revenue kicking in, forgetaboutit! Like some other thread mentioned, 20X from here and more.